pancreatic cancer

'Seena' clinical trials named for pancreatic cancer advocate

EurekAlert! - Cancer  Wed, 11/30/2011 - 23:00

(The Translational Genomics Research Institute) A son's passion to find a cure for the cancer that claimed the life of his mother has led to a new series of clinical trials under a Translational Genomics Research Institute initiative to find a cure for pancreatic cancer.

Roger Magowitz, President of the Seena Magowitz Foundation, has donated $1 million to the TGen pancreatic cancer initiative.


 

Could Steve Jobs have lived longer?

NYDailyNews.com - Health - NY Daily News  Thu, 10/13/2011 - 23:51

Tech titan Steve Jobs' trust in alternative medicine immediately after his pancreatic cancer diagnosis likely shortened his life, a Harvard Medical School researcher contends.


 

Apple Founder Steve Jobs Dies at 56

WebMD Health  Wed, 10/05/2011 - 21:40

Steve Jobs

Steve Jobs, the visionary co-founder of Apple Inc. who revolutionized the way we use technology, died today after fighting advanced pancreatic cancer since 2004.

The death was announced by the company he helped found.


 

Study suggests possible link between two Type 2 diabetes drugs a...

EurekAlert! - Cancer  Thu, 09/15/2011 - 22:00

(University of California - Los Angeles Health Sciences) Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer.


 

FAQ: Steve Jobs' Pancreatic Cancer

WebMD Health  Thu, 08/25/2011 - 17:25

Steve Jobs

`Apple chief Steve Job's appears to be suffering a recurrence of his islet cell neuroendocrine cancer.

WebMD answers frequently asked questions about this uncommon form of pancreatic cancer.


 

Blocking receptor in key hormone fires up enzyme to kill pancrea...

EurekAlert! - Cancer  Tue, 08/09/2011 - 22:00

(Thomas Jefferson University) Pancreatic cancer researchers at Thomas Jefferson University have shown, for the first time, that blocking a receptor of a key hormone in the renin-angiotensin system (RAS) reduces cancer cell growth by activating the enzyme AMPK to inhibit fatty acid synthase, the ingredients to support cell division.


 

Pancreas cancer vaccine trialled

BBC News | Health | World Edition  Thu, 04/14/2011 - 14:07

Doctors say that more than 1,000 UK patients with advanced pancreatic cancer have joined a trial using a vaccine to treat the disease.


 

Soft drink consumption may increase risk of pancreatic cancer

EurekAlert! - Cancer  Sun, 02/07/2010 - 23:00

(American Association for Cancer Research) Increased sugar intake may stimulate tumor growth through effects of insulin.Pancreatic cancer rates increased nearly twofold over the past several decades.Drinking two or more soft drinks a week led to an 87 percent increased risk.


 

Pancreatic Cancer Action Network-AACR Pathway to Leadership Gran...

EurekAlert! - Cancer  Mon, 01/18/2010 - 23:00

(American Association for Cancer Research) The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Zeshaan A.

Rasheed, M.D., Ph.D., the 2010 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant. This grant, totaling $600,000 over five years, will support Rasheed's efforts to examine the relevance of cancer stem cells in pancreatic adenocarcinoma.


 

Discovery offers potential new pancreatic cancer treatment

EurekAlert! - Medicine and Health  Sun, 11/01/2009 - 23:00

(American Association of Pharmaceutical Scientists) Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer.

New research to be presented in November at the American Association of Pharmaceutical Scientists Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.